# RNA localization to nuclear speckles follows splicing logic

**Authors:** Li Wen, Mauricio A Arias, Xinqi Fan, Joyce Xie, Sneha Paul, Susan E Liao, Marek Sobczyk, Oded Regev, Jingyi Fei

PMC · DOI: 10.1093/nar/gkag174 · Nucleic Acids Research · 2026-03-06

## TL;DR

This paper shows that RNA localization to nuclear speckles is closely linked to splicing processes, even in non-spliced transcripts, suggesting a shared mechanism.

## Contribution

The study reveals a novel connection between RNA localization to nuclear speckles and splicing logic, including the role of exon-like and intron-like features.

## Key findings

- Speckle localization is enhanced by unspliced exon-like or intron-like sequence features.
- Disease-associated single nucleotide variants reduce speckle localization of isolated exons.
- Speckle localization correlates with splicing kinetics and influences exon inclusion or skipping decisions.

## Abstract

Nuclear speckles are membraneless organelles implicated in multiple RNA processing steps. In this work, we systematically characterize the sequence logic determining RNA localization to nuclear speckles. We find extensive similarities between the speckle localization code and the RNA splicing code, even for transcripts that do not undergo splicing. Specifically, speckle localization is enhanced by the presence of unspliced exon-like or intron-like sequence features. We demonstrate that interactions required for early spliceosomal complex assembly contribute to speckle localization. We also show that speckle localization of isolated endogenous exons is reduced by disease-associated single nucleotide variants. Finally, we find that speckle localization strongly correlates with splicing kinetics of splicing-competent constructs and is linked to the decision between exon inclusion and skipping. Together, these results suggest a model in which RNA speckle localization is associated with the formation of the early spliceosomal complex and enhances the efficiency of splicing reactions.

Graphical Abstract

## Full-text entities

- **Genes:** NEB (nebulin) [NCBI Gene 4703] {aka AMC6, NEB177D, NEM2}, SRSF1 (serine and arginine rich splicing factor 1) [NCBI Gene 6426] {aka ASF, NEDFBA, SF2, SF2p33, SFRS1, SRp30a}, SRRM2 (serine/arginine repetitive matrix 2) [NCBI Gene 609646], CAT (catalase) [NCBI Gene 847], SNRPA (small nuclear ribonucleoprotein polypeptide A) [NCBI Gene 6626] {aka Mud1, U1-A, U1A}, SON [NCBI Gene 478406], DHFR [NCBI Gene 100689028], COLQ (collagen like tail subunit of asymmetric acetylcholinesterase) [NCBI Gene 8292] {aka CMS5, EAD}, SRRM2 (serine/arginine repetitive matrix 2) [NCBI Gene 23524] {aka 300-KD, CWF21, Cwc21, HSPC075, MRD72, SRL300}, RNASE1 (ribonuclease A family member 1, pancreatic) [NCBI Gene 6035] {aka RAC1, RIB1, RNS1}, SMN2 (survival of motor neuron 2, centromeric) [NCBI Gene 6607] {aka BCD541, C-BCD541, GEMIN1, SMNC, TDRD16B}, RNPS1 (RNA binding protein with serine rich domain 1) [NCBI Gene 10921] {aka E5.1}, HNRNPA1 (heterogeneous nuclear ribonucleoprotein A1) [NCBI Gene 3178] {aka ALS19, ALS20, HNRPA1, HNRPA1L3, IBMPFD3, MPD3}, U2AF1 (U2 small nuclear RNA auxiliary factor 1) [NCBI Gene 7307] {aka FP793, RN, RNU2AF1, U2AF35, U2AFBP}, SON (SON DNA and RNA binding protein) [NCBI Gene 6651] {aka BASS1, C21orf50, DBP-5, NREBP, SON3, TOKIMS}, DNTT (DNA nucleotidylexotransferase) [NCBI Gene 1791] {aka TDT}, hnRNPA1 [NCBI Gene 100769923], HNRNPH2 (heterogeneous nuclear ribonucleoprotein H2) [NCBI Gene 3188] {aka FTP3, HNRPH', HNRPH2, MRXSB, NRPH2, hnRNPH'}, U2AF2 (U2 small nuclear RNA auxiliary factor 2) [NCBI Gene 11338] {aka DEVDFB, U2AF65}, MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) [NCBI Gene 4552] {aka MSR, cblE}, SRSF1 [NCBI Gene 100689086], SMN1 (survival of motor neuron 1, telomeric) [NCBI Gene 6606] {aka BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3}, PNMA2 (PNMA family member 2) [NCBI Gene 10687] {aka MA2, MM2, RGAG2}
- **Diseases:** acetylcholinesterase deficiency (MESH:C566415), spinal muscular atrophy (MESH:D009134), genetic (MESH:D030342)
- **Chemicals:** sodium citrate (MESH:D000077559), HEPES (MESH:D006531), Na (MESH:D012964), penicillin (MESH:D010406), Glycerol (MESH:D005990), formamide (MESH:C031066), Alexa Fluor 647 NHS Ester (-), sodium bicarbonate (MESH:D017693), Lipofectamine (MESH:C086724), lipid (MESH:D008055), paraformaldehyde (MESH:C003043), chloroform (MESH:D002725), (NH4)2SO4 (MESH:D000645), agarose (MESH:D012685), dextran sulfate (MESH:D016264), SYBR Green I (MESH:C098022), Triptolide (MESH:C001899), DMSO (MESH:D004121), DAPI (MESH:C007293), glucose (MESH:D005947), polyA (MESH:D011061), SR (MESH:D013324), Tween 20 (MESH:D011136), PVDF (MESH:C024865), doxycycline (MESH:D004318), MgCl2 (MESH:D015636), NaCl (MESH:D012965), Triton X-100 (MESH:D017830), polyacrylamide (MESH:C016679), streptomycin (MESH:D013307), ethidium bromide (MESH:D004996), EDTA (MESH:D004492), Plad B (MESH:C522342), TRIZol (MESH:C411644), phenol (MESH:D019800), H2O (MESH:D014867), PD (MESH:D010165), ethanol (MESH:D000431), Glycine (MESH:D005998), DTT (MESH:D004229), oligonucleotide (MESH:D009841), PCB114 (MESH:C035834), Neon (MESH:D009356), HCl (MESH:D006851), SDS (MESH:D012967)
- **Species:** Cricetulus griseus (Chinese hamster, species) [taxon 10029], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Mycoplasma (genus) [taxon 2093]
- **Mutations:** M0315L, X50S, R0665S, N0447S, P0753S, R3589S, M0530L, E1011-A, C with 25, 3G
- **Cell lines:** 31 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184), M5'-HN — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_8128), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), '-SR-5 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_S164), 23-88 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_RA75)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12962856/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12962856/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC12962856/full.md

---
Source: https://tomesphere.com/paper/PMC12962856